HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies-Reference-Cited by-同舟云学术

HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies

Published:2014-09-30 Issue:5 Volume:22 Page:400-405
ISSN:2005-4483
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Kim SoRa¹,Kim Dae Hoon¹²,Kim Young-Seok¹,Ha Tae-Young¹,Yang Jin¹,Park Soo Hyun²,Jeong Kwang Won³,Rhee Jae-Keol¹

Affiliation:

1. New Drug Discovery Lab., Hyundai Pharmaceutical Co. Ltd., Gyeong-Gi Bio-Center, Suwon 443-270, Republic of Korea

2. Bio-therapy Human Resources Center, Animal Medical Center and Department of Veterinary Physiology, College of Veterrinary Medicine, Chonnam National University, Gwangju 500-757, Republic of Korea

3. College of Pharmacy, Gachon University, Incheon 406-840, Republic of Korea

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2014/022/bt-22-400.pdf

Reference23 articles.

1. Hypoglycaemia in Type 2 diabetes

2. DPP-4 inhibitors and their potential role in the management of type 2 diabetes

3. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies

4. Sitagliptin-induced hemolysis

5. A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates;Expert Opinion on Investigational Drugs;2024-02-23

2. Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review;Mini-Reviews in Medicinal Chemistry;2023-11

3. Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease;Cellular & Molecular Biology Letters;2021-07-07

4. Structure and biological activity of endogenous and synthetic agonists of GPR119;Russian Chemical Reviews;2018-02-01

5. Therapeutic application ofGPR119ligands in metabolic disorders;Diabetes, Obesity and Metabolism;2017-08-22